Acoustic Neuroma Market
- 2026 年市場規模
- USD 2.04 Bn
- 2033 年預估規模
- USD 3.37 Bn
- 年複合成長率 CAGR
- 7.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
完整報告名稱與涵蓋範圍
Acoustic Neuroma Market, By Disease Type (Sporadic Acoustic Neuroma, Neurofibromatosis Type 2-Associated Acoustic Neuroma), By Treatment Type (Microsurgical Resection, Stereotactic Radiosurgery, Fractionated Radiotherapy, Observation / Watchful Waiting, Drug Therapy), By Diagnosis (Magnetic Resonance Imaging (MRI), Audiometry, Vestibular Testing, Others), By Tumor Size (Small Tumors, Medium Tumors, Large Tumors), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic and Research Institutes, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global acoustic neuroma market is estimated to be valued at USD 2.04 Bn in 2026 and is expected to reach USD 3.37 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033. Acoustic neuroma or vestibular schwannoma is a benign tumor of the vestibulocochlear nerve, which slowly grows and mainly affects hearing and balance. The global acoustic neuroma market comprises diagnostic imaging, microsurgery, stereotactic radiosurgery, radiotherapy, observation, and limited drug therapies, wherein advances in MRI and minimally invasive procedures have facilitated faster and more personalized treatment.
The global acoustic neuroma market is driven by increasing specialization among neurosurgeons, otolaryngologists and radiation oncologists, and growing awareness about rare neurological disorders. Increasing investments in neurological research, advanced neuroimaging and precision treatment technologies are expected to fuel the adoption of the acoustic neuroma diagnosis and treatment solutions worldwide.
Market Dynamics
The global acoustic neuroma market is driven by the enhanced detection of acoustic neuroma with advanced MRI, growing awareness about vestibular disorders, and increasing adoption of minimally invasive treatments such as Gamma Knife and CyberKnife radiosurgery. Furthermore, increasing healthcare expenditure, specialized neurological care and better availability of advanced treatment technologies further bolster market growth.
However, a number of constraints are present in the market, such as high treatment costs, limited access to specialized care, and risks such as hearing loss and facial nerve complications. Nevertheless, significant opportunities exist in AI-enabled neuroimaging, healthcare infrastructure expansion across emerging markets, and research into targeted drug therapies.
Key Features of the Study
• This report provides in-depth analysis of the global acoustic neuroma market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global acoustic neuroma market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Elekta AB, Accuray Incorporated, Siemens Healthineers AG, GE HealthCare Technologies Inc., Natus Medical Incorporated, Canon Medical Systems Corporation, Medtronic plc, Brainlab AG, Stryker Corporation, and Carl Zeiss Meditec AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global acoustic neuroma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acoustic neuroma market
Market Segmentation
• Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
o Sporadic Acoustic Neuroma
o Neurofibromatosis Type 2-Associated Acoustic Neuroma
• Treatment Type Insights (Revenue, USD Bn, 2021 - 2033)
o Microsurgical Resection
o Stereotactic Radiosurgery
o Fractionated Radiotherapy
o Observation / Watchful Waiting
o Drug Therapy
• Diagnosis Insights (Revenue, USD Bn, 2021 - 2033)
o Magnetic Resonance Imaging (MRI)
o Audiometry
o Vestibular Testing
o Others
• Tumor Size Insights (Revenue, USD Bn, 2021 - 2033)
o Small Tumors
o Medium Tumors
o Large Tumors
• End User Insights (Revenue, USD Bn, 2021 - 2033)
o Hospitals
o Specialty Clinics
o Ambulatory Surgical Centers
o Academic and Research Institutes
o Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Elekta AB
o Accuray Incorporated
o Siemens Healthineers AG
o GE HealthCare Technologies Inc.
o Natus Medical Incorporated
o Canon Medical Systems Corporation
o Medtronic plc
o Brainlab AG
o Stryker Corporation
o Carl Zeiss Meditec AG
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Acoustic Neuroma Market, By Disease Type
Global Acoustic Neuroma Market, By Treatment Type
Global Acoustic Neuroma Market, By Diagnosis
Global Acoustic Neuroma Market, By Tumor Size
Global Acoustic Neuroma Market, By End User
Global Acoustic Neuroma Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Disease Type Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Industry Trends
4. Global Acoustic Neuroma Market, By Disease Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Sporadic Acoustic Neuroma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Neurofibromatosis Type 2-Associated Acoustic Neuroma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Acoustic Neuroma Market, By Treatment Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Microsurgical Resection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Stereotactic Radiosurgery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Fractionated Radiotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Observation / Watchful Waiting
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Drug Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Acoustic Neuroma Market, By Diagnosis, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Magnetic Resonance Imaging (MRI)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Audiometry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Vestibular Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Acoustic Neuroma Market, By Tumor Size, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Small Tumors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Medium Tumors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Large Tumors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Acoustic Neuroma Market, By End User, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Academic and Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Acoustic Neuroma Market, By Region, 2021 - 2033, Value (USD Bn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Diagnosis, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Tumor Size, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
o South Africa
o North Africa
o Central Africa
10. Competitive Landscape
o Elekta AB
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o Accuray Incorporated
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o Siemens Healthineers AG
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o GE HealthCare Technologies Inc.
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o Natus Medical Incorporated
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o Canon Medical Systems Corporation
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o Medtronic plc
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o Brainlab AG
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o Stryker Corporation
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
o Carl Zeiss Meditec AG
Company Highlights
Disease Type Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
12. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Acoustic Neuroma Market' - Global forecast to 2033
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們